These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3653233)

  • 1. Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers.
    Goldstein DA; Tan YK; Soldin SJ
    Eur J Clin Pharmacol; 1987; 32(6):631-4. PubMed ID: 3653233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and relative bioavailability of salbutamol metered-dose inhaler in healthy volunteers.
    Du XL; Zhu Z; Fu Q; Li DK; Xu WB
    Acta Pharmacol Sin; 2002 Jul; 23(7):663-6. PubMed ID: 12100764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the pharmacokinetics and relative bioavailability of salbutamol aerosol in healthy volunteers].
    Du XL; Zhu Z; Fu Q; Li DK; Xu WB
    Yao Xue Xue Bao; 2001 Aug; 36(8):616-20. PubMed ID: 12579942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic comparison of a dextromethorphan-salbutamol combination tablet and a plain dextromethorphan tablet.
    Silvasti M; Karttunen P; Happonen P; Mykkänen M; Romppanen T; Tukiainen H
    Int J Clin Pharmacol Ther Toxicol; 1990 Jun; 28(6):268-72. PubMed ID: 2376428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantioselective disposition of salbutamol in man following oral and intravenous administration.
    Boulton DW; Fawcett JP
    Br J Clin Pharmacol; 1996 Jan; 41(1):35-40. PubMed ID: 8824691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability of dilevalol in normotensive volunteers.
    Kramer WG; Nagabhushan N; Affrime MB; Perentesis GP; Symchowicz S; Patrick JE
    J Clin Pharmacol; 1988 Jul; 28(7):644-8. PubMed ID: 3216030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of hydroxy-3(S)-dihydroquinidine in healthy volunteers after intravenous and oral administration.
    Jaillon P; Poirier JM; Lecocq B; Jarreau C; Pays M; Richard MO; Cheymol G
    Eur J Drug Metab Pharmacokinet; 1986; 11(3):233-8. PubMed ID: 3816879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and absolute bioavailability of diltiazem in humans.
    Ochs HR; Knüchel M
    Klin Wochenschr; 1984 Apr; 62(7):303-6. PubMed ID: 6727272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
    He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
    Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of intravenous salbutamol in renal insufficiency and its biological effects.
    Rey E; Luquel L; Richard MO; Mory B; Offenstadt G; Olive G
    Eur J Clin Pharmacol; 1989; 37(4):387-9. PubMed ID: 2598971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bioavailability of heptaminol in healthy subjects].
    Kees F; Dominiak P; Grobecker H
    Arzneimittelforschung; 1987 Oct; 37(10):1182-5. PubMed ID: 3435592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of valproic acid obtained after administration of three oral formulations to humans.
    Bialer M; Hussein Z; Dubrovsky J; Raz I; Abramsky O
    Isr J Med Sci; 1984 Jan; 20(1):46-9. PubMed ID: 6421770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and relative bioavailability of selegiline in healthy volunteers.
    Mahmood I; Marinac JS; Willsie S; Mason WD
    Biopharm Drug Dispos; 1995 Oct; 16(7):535-45. PubMed ID: 8785378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative pharmacokinetics of three oral 400 mg ibuprofen dosage forms in healthy volunteers.
    Saano V; Paronen P; Peura P; Vidgren M
    Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):381-5. PubMed ID: 1748537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of food on the absorption of albuterol Repetabs.
    Bolinger AM; Young KY; Gambertoglio JG; Newth CJ; Zureikat G; Powell M; Leung P; Affrime MB; Symchowicz S; Patrick JE
    J Allergy Clin Immunol; 1989 Jan; 83(1):123-6. PubMed ID: 2913132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and systemic availability of the antihypertensive agent indoramin and its metabolite 6-hydroxyindoramin in healthy subjects.
    Pierce DM; Abrams SM; Franklin RA
    Eur J Clin Pharmacol; 1987; 32(6):619-23. PubMed ID: 3653231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.